DAVID GREEN - 25 Jan 2023 Form 4 Insider Report for Biostage, Inc. (HRGN)

Role
CEO, Director
Signature
/s/ Joseph Damasio, by power of attorney
Issuer symbol
HRGN
Transactions as of
25 Jan 2023
Net transactions value
$0
Form type
4
Filing time
27 Jan 2023, 09:52:54 UTC
Previous filing
23 May 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Stock Option (right to buy) Award $0 +47,651 $0.000000 47,651 25 Jan 2023 Common Stock, par value $0.01 per share 47,651 $6.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued employment through the applicable vesting dates, the non-qualified stock option will vest monthly in twelve equal monthly installments on each monthly anniversary of January 25, 2023.